ORIGINAL RESEARCH
Published on 06 Jun 2025
Efficacy and safety of Eribulin-based chemotherapy in HER2 negative advanced breast cancer patients: a real-world study
doi 10.3389/fonc.2025.1499701
- 542 views
956
Total downloads
4,197
Total views and downloads
ORIGINAL RESEARCH
Published on 06 Jun 2025
ORIGINAL RESEARCH
Accepted on 13 May 2025
ORIGINAL RESEARCH
Published on 10 Mar 2025
SYSTEMATIC REVIEW
Published on 28 Feb 2025